Session 21
Evolving Concepts in Dermatology Part XVIII

About
Faculty
Learning Objectives
Intended Audience
Accreditation Statement
Credit Designation Statement
Disclosure
Disclaimer

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.

This week, we will be coming to you LIVE!
Wednesday, December 2, 2020
8 PM EDT/ 5 PM PDT

EVOLVING CONCEPTS IN DERMATOLOGY PART XVIII

Assessing Risk of Sentinel Node Positivity

Gene Expression Profile Testing for Melanoma Diagnosis

Laura Ferris, MD, PhD

Faculty

Associate Professor of Dermatology
University of Pittsburgh
Pittsburgh, PA

Shannon Trotter, DO

Faculty

Clinical Assistant Professor of Dermatology, Ohio University
Associate Program Director, OhioHealth Dermatology Residency Program
Private Practice Dermatologists of Central States
Columbus, OH

Upon completion of this activity, the participant should be better able to:

Examine the value of the 31-GEP test to assess individual risk of sentinel lymph node positivity and inform management decisions in melanoma patients.
Discuss the appropriate clinical use of gene expression profiling in diagnosing melanoma

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Almirall.

CONFLICTS OF INTEREST/DISCLOSURES

Laura Ferris, MD

Consultant: DermTech, Scibase

Grant/Research Support: Castle Biosciences

Shannon Trotter, MD

Consultant: Castle Biosciences

Grant/Research Support: Castle Biosciences

Speakers’ Bureau: Amgen, Castle Biosciences, Pfizer, Sun Pharmaceuticals

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

[fc+321]

Session 21 Evolving Concepts in Dermatology Part XVIII

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.This week, we will be coming to you LIVE!Wednesday, December 2, 20208 PM EDT/ 5 PM PDTEVOLVING CONCEPTS IN DERMATOLOGY PART XVIII

Laura Ferris, MD, PhD

Shannon Trotter, DO

CONFLICTS OF INTEREST/DISCLOSURES

Session 21
Evolving Concepts in Dermatology Part XVIII

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.

This week, we will be coming to you LIVE!
Wednesday, December 2, 2020
8 PM EDT/ 5 PM PDT

EVOLVING CONCEPTS IN DERMATOLOGY PART XVIII